Matches in SemOpenAlex for { <https://semopenalex.org/work/W3101818514> ?p ?o ?g. }
- W3101818514 abstract "Abstract Background Poly(ADP-ribose) polymerase inhibitors (PARPis) specifically target homologous recombination deficiency (HRD) cells and display good therapeutic effect in women with advanced-stage BRCA1/2-mutated breast and epithelial ovarian cancer (EOC). However, about 50% of high grade serous ovarian cancers (HGSOC) present with HRD due to epigenetic BRCA1 inactivation, as well as genetic/epigenetic inactivation(s) of other HR genes, a feature known as “BRCAness”. Therefore, there is a potential for extending the use of PARPis to these patients if HR status can be identified. Methods We have developed a 3D (spheroid) functional assay to assess the sensitivity of two PARPis (niraparib and olaparib) in ascites-derived primary cell cultures (AsPCs) from HGSOC patients. A method for AsPCs preparation was established based on a matrix (agarose), allowing for easy isolation and successive propagation of monolayer and 3D AsPCs. Based on this method, we performed cytotoxicity assays on 42 AsPCs grown both as monolayers and spheroids. Results The response to PARPis treatment in monolayer AsPCs, was significantly higher, compared to 3D AsPCs, as 88% and 52% of the monolayer AsPCs displayed sensitivity to niraparib and olaparib respectively, while 66% of the 3D AsPCs were sensitive to niraparib and 38% to olaparib, the latter being more consistent with previous estimates of HRD (40%–60%) in EOC. Moreover, niraparib displayed a significantly stronger cytotoxic effect in both in 3D and monolayer AsPCs, which was confirmed by consecutive analyses of the HR pathway activity (γH2AX foci formation) in PARPis-sensitive and resistant AsPCs. Global gene expression comparison of 6 PARPi-resistant and 6 PARPi-sensitive 3D AsPCs was indicative for the predominant downregulation of numerous genes and networks with previously demonstrated roles in EOC chemoresistance, suggesting that the PARPis-sensitive AsPCs could display enhanced sensitivity to other chemotherapeutic drugs, commonly applied in cancer management. Microarray data validation identified 24 potential gene biomarkers associated with PARPis sensitivity. The differential expression of 7 selected biomarkers was consecutively confirmed by immunohistochemistry in matched EOC tumor samples. Conclusion The application of this assay and the potential biomarkers with possible predictive significance to PARPis therapy of EOC patients now need testing in the setting of a clinical trial." @default.
- W3101818514 created "2020-11-23" @default.
- W3101818514 creator A5022422757 @default.
- W3101818514 creator A5033540995 @default.
- W3101818514 creator A5038025657 @default.
- W3101818514 creator A5051798074 @default.
- W3101818514 creator A5053934915 @default.
- W3101818514 creator A5073761346 @default.
- W3101818514 creator A5076716605 @default.
- W3101818514 creator A5079888845 @default.
- W3101818514 creator A5087341200 @default.
- W3101818514 creator A5091028771 @default.
- W3101818514 date "2020-11-19" @default.
- W3101818514 modified "2023-10-18" @default.
- W3101818514 title "Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy" @default.
- W3101818514 cites W1484356204 @default.
- W3101818514 cites W1523531555 @default.
- W3101818514 cites W1536922619 @default.
- W3101818514 cites W1839613638 @default.
- W3101818514 cites W1966051785 @default.
- W3101818514 cites W1967532587 @default.
- W3101818514 cites W1968002492 @default.
- W3101818514 cites W1970391983 @default.
- W3101818514 cites W1973188720 @default.
- W3101818514 cites W1974409934 @default.
- W3101818514 cites W1979921319 @default.
- W3101818514 cites W1979948285 @default.
- W3101818514 cites W1986471561 @default.
- W3101818514 cites W1987473368 @default.
- W3101818514 cites W1991102099 @default.
- W3101818514 cites W1994209879 @default.
- W3101818514 cites W1994843494 @default.
- W3101818514 cites W1995480433 @default.
- W3101818514 cites W2002962154 @default.
- W3101818514 cites W2004761363 @default.
- W3101818514 cites W2009863035 @default.
- W3101818514 cites W2010916968 @default.
- W3101818514 cites W2020781975 @default.
- W3101818514 cites W2036952999 @default.
- W3101818514 cites W2037221338 @default.
- W3101818514 cites W2042101240 @default.
- W3101818514 cites W2055599797 @default.
- W3101818514 cites W2055866442 @default.
- W3101818514 cites W2056569074 @default.
- W3101818514 cites W2058073053 @default.
- W3101818514 cites W2059586354 @default.
- W3101818514 cites W2064070540 @default.
- W3101818514 cites W2068372669 @default.
- W3101818514 cites W2070835754 @default.
- W3101818514 cites W2079647316 @default.
- W3101818514 cites W2081186252 @default.
- W3101818514 cites W2088356680 @default.
- W3101818514 cites W2090722243 @default.
- W3101818514 cites W2091882385 @default.
- W3101818514 cites W2096674608 @default.
- W3101818514 cites W2097484755 @default.
- W3101818514 cites W2105772211 @default.
- W3101818514 cites W2106157865 @default.
- W3101818514 cites W2109243577 @default.
- W3101818514 cites W2116987967 @default.
- W3101818514 cites W2117177285 @default.
- W3101818514 cites W2117964602 @default.
- W3101818514 cites W2123696077 @default.
- W3101818514 cites W2126633009 @default.
- W3101818514 cites W2127496658 @default.
- W3101818514 cites W2129355295 @default.
- W3101818514 cites W2147111123 @default.
- W3101818514 cites W2159848944 @default.
- W3101818514 cites W2254720258 @default.
- W3101818514 cites W2255555283 @default.
- W3101818514 cites W2264528830 @default.
- W3101818514 cites W2270704840 @default.
- W3101818514 cites W2271458278 @default.
- W3101818514 cites W2327298320 @default.
- W3101818514 cites W2332185934 @default.
- W3101818514 cites W2344114823 @default.
- W3101818514 cites W2346066981 @default.
- W3101818514 cites W2400307281 @default.
- W3101818514 cites W2404952574 @default.
- W3101818514 cites W2408982653 @default.
- W3101818514 cites W2462818054 @default.
- W3101818514 cites W2472306545 @default.
- W3101818514 cites W2476470567 @default.
- W3101818514 cites W2507330949 @default.
- W3101818514 cites W2522879835 @default.
- W3101818514 cites W2526716574 @default.
- W3101818514 cites W2549037212 @default.
- W3101818514 cites W2554128115 @default.
- W3101818514 cites W2570618306 @default.
- W3101818514 cites W2588635345 @default.
- W3101818514 cites W2596164112 @default.
- W3101818514 cites W2623049878 @default.
- W3101818514 cites W2655582795 @default.
- W3101818514 cites W2744284737 @default.
- W3101818514 cites W2751441869 @default.
- W3101818514 cites W2754327139 @default.
- W3101818514 cites W2761200174 @default.
- W3101818514 cites W2763049992 @default.
- W3101818514 cites W2763819270 @default.
- W3101818514 cites W2765144178 @default.